6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Oorspronkelijke tekst

Deze vertaling beoordelen

Je feedback wordt gebruikt om Google Translate te verbeteren

Latest Press Releases

Time	Headline
8m ago	Nayax to Report 2026 Q1 Earnings on May 12, 2026
35m ago	CC Capital and OneIM Complete Acquisition of Insignia Financial Limited, Australia's Leading Diversified Wealth Management Group
1h ago	Canadian Gold Resources Strengthens Board with Capital Markets Veteran Kenneth Chernin
1h ago	Waraba Gold Signs Binding Agreement to Establish Joint Venture Relating to Tengrela South Exploration Permit Application in Cote d'Ivoire
1h ago	Sierra Madre Announces Shareholder Approval of Acquisition of Del Toro Silver Mine

About

Gyre Therapeutics Inc. (NASDAQ:GYRE) — investor relations, events, news, and company updates on 6ix.

Latest News

Gyre Therapeutics Announces China’s NMPA Grants Priority Review to the NDA for Hydronidone (F351) for CHB-Induced Liver Fibrosis Treatment

Gyre Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

Gyre Therapeutics Enters into Agreement to Acquire Cullgen to Gain Targeted Protein Degradation Platform and Pipeline

Gyre Therapeutics Announces Alignment with China’s CDE on Conditional Approval Pathway and Priority Review Eligibility for Hydronidone Following Pre-NDA Meeting

Gyre Therapeutics Reports Third Quarter 2025 and Year-to-Date Financial Results and Provides Business Update

Financials

Revenue

$116.59 M

Market Cap

$685.89 M

P/E Ratio

356.00

EPS

0.02

Community Chat

Ask AI